Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2001, HBM Partners AG is a Swiss venture capital firm with $2.1 billion in assets under management. The firm focuses on venture, growth, and buy-out financings in the biopharma, medtech, diagnostics, and healthcare sectors. Operating primarily in Europe and North America, HBM also explores opportunities in emerging markets like India and China.
HBM Partners invests in the biopharma, medtech, diagnostics, and healthcare sectors, with check sizes ranging from $5 million to $50 million. Their investment strategy encompasses both private and public companies, supporting growth through various stages of development.
HBM Partners has made over 100 investments, achieving more than 60 successful exits through trade sales and IPOs.
Submit your pitch through their form at hbmpartners.com.
HBM Partners invests across multiple stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity.
The firm typically invests between $5 million and $50 million in its portfolio companies.
HBM Partners primarily operates in North America and Europe, with additional investments in emerging markets such as India and China.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.